Published Research Summaries (click "Search" in Menu to filter)

Joint smoking study: The second half is always "stronger"

The transition of cannabinoids and terpenes in cannabis from "solid" to vapor or smoke in a joint (cannabis cigarette) was examined. It was published in the journal Cannabis and Cannabinoid Research in October 2023.
Read more

Cannabis helps anxiety patients get better sleep

Participants self-reported their sleep quality, alcohol use, and cannabis use daily for 30 days via a dairy. It was published in November 2023 in the Drug and Alcohol Review from the Australasian Professional Society on Alcohol and other Drugs.
Read more

Male cannabis users have lower kidney stone risk, female users do not

Using data from the U.S. National Health and Nutrition Examination Survey (NHANES) from 2009 to 2018, this study sought to determine if there was an association between marijuana use and kidney stones.
Read more

Cannabis improves pain symptoms in non-responsive cancer patients

Many cancer patients do not respond to traditional pharmaceutical pain interventions. This study examined the self-reported effectiveness of medical cannabis on pain in non-responsive cancer patients.
Read more

Study concludes cannabis users do not show increased heart disease risk factors

Published in November 2023 in the journal Circulation: Cardiovascular Quality and Outcomes, this study examined data collected by the US National Health And Nutrition Examination Survey from 2005 to 2018.
Read more

Patients report CBD is effective for managing stress

Both products showed statistically significant stress-reducing abilities. Of the participants who rated the product's ability to manage stress as a 10 out of 10, about twice as many were using the broad spectrum product.
Read more

In vitro study shows CBD extract kills melanoma cells

Using a full spectrum CBD hemp extract, this study examined its effects on several melanoma cell lines. It was published in October 2023 in the journal Cells.
Read more

CBD shown to be effective for dental pain

This was a randomized placebo-controlled trial to determine the effects of CBD on moderate to severe toothaches. It was published in the Journal of Dental Research in November 2023.
Read more

Daily CBG treatment shows effectiveness for chemo-induced neuropathic pain in mice

This study used mice to create chemotherapy-induced peripheral neuropathic pain, then determine if administration of CBG had an effect. It was published in the journal Pharmaceuticals in October 2023. 
Read more

2023 Study: CBD and THC are effective for Social Anxiety, but ONLY at the right dose

This review study examined the subjective, behavioral, and neurobiological effects of cannabis and cannabinoids in social anxiety and Social Anxiety Disorder. It was published in the journal Reviews in the Neurosciences in October 2023.
Read more

CBD for 8 weeks improves sleep quality and immune cell function

This randomized double-blind, placebo-controlled intervention examined the effects of a specific dose of daily CBD on mental health, sleep quantity and quality, and immune cell function in healthy college-aged adults. It was published in September 2023 in the journal Nutrients.
Read more

CBD shows promise for Leukemia treatment

Administration of CBD resulted in a significant improvement in the biochemical, antioxidant status, morphological, and molecular measures in DMBA-induced leukemia in adult male rats. The study was published in Naunyn-Schmiedeberg's Archives in Pharmacology in October 2023.
Read more

Human brain activity shows full spectrum cannabis is more psychoactive

This study was conducted by two companies involved in the production of cannabis and hemp related products, so it is not purely academic. However, it involves direct brainwave measurements that could be important in determining product types and doses for patients and consumers. 
Read more

THCV, CBC, and CBN show anti-inflammatory effects

This in vitro study examined the anti-inflammatory effects of the non-euphoric cannabinoids THCV, CBC, and CBN. It was published in the journal Molecules in September 2023.
Read more

Chronic, treatment-resistant patients show clinically meaningful improvement with medical cannabis

This study assessed health-related quality of life (HRQL), pain, fatigue, sleep, anxiety, and depression in treatment-resistant patients prescribed medical cannabis by their doctor. It was published in the journal PLOS ONE in September 2023.
Read more

Double-blind study shows CBD lowers blood pressure over 24 hours

It was a double-blind, randomized, placebo-controlled cross-over pilot study on 16 patients with untreated high blood pressure and was published in August 2023 in the journal Advances in Therapy.
Read more

Full spectrum cannabis increases bioavailability of CBD

This study's goal was to determine how much CBD gets into the bloodstream when full spectrum CBD, broad spectrum CBD, or CBD isolate is administered orally. It was published in the European Journal of Drug Metabolism and Pharmacokinetics in June 2023.
Read more

91% of U.S. Veterans report quality of life improvements because of cannabinoid medicine

510 Veterans self-reported via a detailed survey in 2019 about their use of cannabis based medicines to manage several conditions and symptoms. It was published in June 2023 in the journal Clinical Therapeutics. 
Read more
ads: